Literature DB >> 25355880

Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.

Yi-Ping Li1, Santseharay Ramirez1, Lotte Mikkelsen1, Jens Bukh2.   

Abstract

UNLABELLED: The first discovered and sequenced hepatitis C virus (HCV) genome and the first in vivo infectious HCV clones originated from the HCV prototype strains HCV-1 and H77, respectively, both widely used in research of this important human pathogen. In the present study, we developed efficient infectious cell culture systems for these genotype 1a strains by using the HCV-1/SF9_A and H77C in vivo infectious clones. We initially adapted a genome with the HCV-1 5'UTR-NS5A (where UTR stands for untranslated region) and the JFH1 NS5B-3'UTR (5-5A recombinant), including the genotype 2a-derived mutations F1464L/A1672S/D2979G (LSG), to grow efficiently in Huh7.5 cells, thus identifying the E2 mutation S399F. The combination of LSG/S399F and reported TNcc(1a)-adaptive mutations A1226G/Q1773H/N1927T/Y2981F/F2994S promoted adaptation of the full-length HCV-1 clone. An HCV-1 recombinant with 17 mutations (HCV1cc) replicated efficiently in Huh7.5 cells and produced supernatant infectivity titers of 10(4.0) focus-forming units (FFU)/ml. Eight of these mutations were identified from passaged HCV-1 viruses, and the A970T/I1312V/C2419R/A2919T mutations were essential for infectious particle production. Using CD81-deficient Huh7 cells, we further demonstrated the importance of A970T/I1312V/A2919T or A970T/C2419R/A2919T for virus assembly and that the I1312V/C2419R combination played a major role in virus release. Using a similar approach, we found that NS5B mutation F2994R, identified here from culture-adapted full-length TN viruses and a common NS3 helicase mutation (S1368P) derived from viable H77C and HCV-1 5-5A recombinants, initiated replication and culture adaptation of H77C containing LSG and TNcc(1a)-adaptive mutations. An H77C recombinant harboring 19 mutations (H77Ccc) replicated and spread efficiently after transfection and subsequent infection of naive Huh7.5 cells, reaching titers of 10(3.5) and 10(4.4) FFU/ml, respectively. IMPORTANCE: Hepatitis C virus (HCV) was discovered in 1989 with the cloning of the prototype strain HCV-1 genome. In 1997, two molecular clones of H77, the other HCV prototype strain, were shown to be infectious in chimpanzees, but not in vitro. HCV research was hampered by a lack of infectious cell culture systems, which became available only in 2005 with the discovery of JFH1 (genotype 2a), a genome that could establish infection in Huh7.5 cells. Recently, we developed in vitro infectious clones for genotype 1a (TN), 2a (J6), and 2b (J8, DH8, and DH10) strains by identifying key adaptive mutations. Globally, genotype 1 is the most prevalent. Studies using HCV-1 and H77 prototype sequences have generated important knowledge on HCV. Thus, the in vitro infectious clones developed here for these 1a strains will be of particular value in advancing HCV research. Moreover, our findings open new avenues for the culture adaptation of HCV isolates of different genotypes.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25355880      PMCID: PMC4301150          DOI: 10.1128/JVI.02877-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA.

Authors:  Catherine L Jopling; Minkyung Yi; Alissa M Lancaster; Stanley M Lemon; Peter Sarnow
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

2.  A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes.

Authors:  Carla Kuiken; Christophe Combet; Jens Bukh; Tadasu Shin-I; Gilbert Deleage; Masashi Mizokami; Russell Richardson; Erwin Sablon; Karina Yusim; Jean-Michel Pawlotsky; Peter Simmonds
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

Review 3.  Replication of hepatitis C virus.

Authors:  Darius Moradpour; François Penin; Charles M Rice
Journal:  Nat Rev Microbiol       Date:  2007-05-08       Impact factor: 60.633

4.  In vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells.

Authors:  Akito Sakai; Shingo Takikawa; Robert Thimme; Jean-Christophe Meunier; Hans Christian Spangenberg; Sugantha Govindarajan; Patrizia Farci; Suzanne U Emerson; Francis V Chisari; Robert H Purcell; Jens Bukh
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

5.  Production of infectious hepatitis C virus of various genotypes in cell cultures.

Authors:  Takanobu Kato; Takuya Matsumura; Theo Heller; Satoru Saito; Ronda K Sapp; Krishna Murthy; Takaji Wakita; T Jake Liang
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

6.  Generation of infectious hepatitis C virus in immortalized human hepatocytes.

Authors:  Tatsuo Kanda; Arnab Basu; Robert Steele; Takaji Wakita; Jan S Ryerse; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

7.  Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.

Authors:  Judith M Gottwein; Troels K H Scheel; Anne M Hoegh; Jacob B Lademann; Jesper Eugen-Olsen; Gorm Lisby; Jens Bukh
Journal:  Gastroenterology       Date:  2007-08-03       Impact factor: 22.682

8.  Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies.

Authors:  Zania Stamataki; Stephen Coates; Matthew J Evans; Mark Wininger; Kevin Crawford; Christine Dong; Yiu-Lian Fong; David Chien; Sergio Abrignani; Peter Balfe; Charles M Rice; Jane A McKeating; Michael Houghton
Journal:  Vaccine       Date:  2007-09-14       Impact factor: 3.641

9.  Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells.

Authors:  MinKyung Yi; Rodrigo A Villanueva; David L Thomas; Takaji Wakita; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

10.  Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees.

Authors:  Jens Bukh; Thomas Pietschmann; Volker Lohmann; Nicole Krieger; Kristina Faulk; Ronald E Engle; Sugantha Govindarajan; Max Shapiro; Marisa St Claire; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

View more
  17 in total

1.  A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I.

Authors:  Adam Zuiani; Kevin Chen; Megan C Schwarz; James P White; Vincent C Luca; Daved H Fremont; David Wang; Matthew J Evans; Michael S Diamond
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

2.  Patch-Clamp Study of Hepatitis C p7 Channels Reveals Genotype-Specific Sensitivity to Inhibitors.

Authors:  Ulrike Breitinger; Noha S Farag; Nourhan K M Ali; Hans-Georg A Breitinger
Journal:  Biophys J       Date:  2016-06-07       Impact factor: 4.033

3.  Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.

Authors:  Asako Murayama; Nao Sugiyama; Ryosuke Suzuki; Masaki Moriyama; Noriko Nakamura; Hidenori Mochizuki; Takaji Wakita; Takanobu Kato
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

4.  Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment.

Authors:  Elena Moreno; Isabel Gallego; Josep Gregori; Adriana Lucía-Sanz; María Eugenia Soria; Victoria Castro; Nathan M Beach; Susanna Manrubia; Josep Quer; Juan Ignacio Esteban; Charles M Rice; Jordi Gómez; Pablo Gastaminza; Esteban Domingo; Celia Perales
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

5.  Substitutions at NS3 Residue 155, 156, or 168 of Hepatitis C Virus Genotypes 2 to 6 Induce Complex Patterns of Protease Inhibitor Resistance.

Authors:  Sanne B Jensen; Stéphanie B N Serre; Daryl G Humes; Santseharay Ramirez; Yi-Ping Li; Jens Bukh; Judith M Gottwein
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

6.  PPP2R5D promotes hepatitis C virus infection by binding to viral NS5B and enhancing viral RNA replication.

Authors:  Muhammad Ikram Anwar; Ni Li; Qing Zhou; Mingxiao Chen; Chengguang Hu; Tao Wu; Haihang Chen; Yi-Ping Li; Yuanping Zhou
Journal:  Virol J       Date:  2022-07-14       Impact factor: 5.913

Review 7.  Experimental models of hepatitis B and C - new insights and progress.

Authors:  Emmanuel Thomas; T Jake Liang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-14       Impact factor: 46.802

8.  Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors.

Authors:  Long V Pham; Santseharay Ramirez; Thomas H R Carlsen; Yi-Ping Li; Judith M Gottwein; Jens Bukh
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

9.  Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.

Authors:  Christian K Mathiesen; Jannick Prentoe; Luke W Meredith; Tanja B Jensen; Henrik Krarup; Jane A McKeating; Judith M Gottwein; Jens Bukh
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

10.  Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins.

Authors:  Fang Chen; Netanel Tzarum; Xiaohe Lin; Erick Giang; Rodrigo Velázquez-Moctezuma; Elias H Augestad; Kenna Nagy; Linling He; Mayda Hernandez; Mallorie E Fouch; Ariadna Grinyó; Deborah Chavez; Benjamin J Doranz; Jannick Prentoe; Robyn L Stanfield; Robert Lanford; Jens Bukh; Ian A Wilson; Jiang Zhu; Mansun Law
Journal:  Immunity       Date:  2021-03-05       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.